Publication detail

Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

CHAROUSOVÁ, M. DOSTÁLOVÁ, S. HEGER, Z. ADAM, V.

Original Title

Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

Type

conference paper

Language

English

Original Abstract

Small interfering RNA also known as siRNA are a short 21-23 base-pair RNA duplexes. Its leading strand is complementary to a sequence of mRNA. Interaction between mRNA and siRNA leads sequence-specific gene expression suppression, also known as RNA interference (RNAi). RNAi was first discovered in plants and later was demonstrated in Caenorhabditis elegans. Now it is known, that this mechanism can be naturally found also in mammalian cells.

Keywords

siRNA; Apoferritin; Cancer Cells

Authors

CHAROUSOVÁ, M.; DOSTÁLOVÁ, S.; HEGER, Z.; ADAM, V.

Released

5. 9. 2018

ISBN

2296-9667

Periodical

European & Global Summit for Clinical Nanomedicine and Targeted Medicine

State

Swiss Confederation

Pages from

173

Pages to

174

Pages count

2

BibTex

@inproceedings{BUT151237,
  author="Markéta {Charousová} and Simona {Dostálová} and Zbyněk {Heger} and Vojtěch {Adam}",
  title="Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells",
  booktitle="CLINAM 2018",
  year="2018",
  journal="European & Global Summit for Clinical Nanomedicine and Targeted Medicine",
  pages="173--174",
  issn="2296-9667"
}